Emerging Therapies in Severe Eosinophilic Asthma

被引：1
作者：
Pang, Pee Hwee [1 ]
Brightling, Christopher E. [2 ,3 ]
机构：
[1] Tan Tock Seng Hosp, Dept Resp & Crit Care Med, Singapore, Singapore
[2] Univ Leicester, Dept Infect Immun & Inflammat, NIHR Resp Biomed Res Unit, Inst Lung Hlth, Leicester, Leics, England
[3] Univ Hosp Leicester NHS Trust, Leicester, Leics, England
来源：
ARCHIVOS DE BRONCONEUMOLOGIA | 2017年 / 53卷 / 05期
关键词：
DOUBLE-BLIND; INHALED CORTICOSTEROIDS; MEPOLIZUMAB; EFFICACY; PHASE-3; SAFETY; BENRALIZUMAB; MULTICENTER;
D O I：
10.1016/j.arbres.2017.01.012
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：233 / 234
页数：2
相关论文
共 50 条
  • [21] Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma
    Gonzalez I, Davila
    Benitez F, Moreno
    Quirce, S.
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (02) : 84 - 93
  • [22] Emerging therapies for eosinophilic esophagitis
    Greuter, Thomas
    Hirano, Ikuo
    Dellon, Evan S.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (01) : 38 - 45
  • [23] Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis
    Tsurumaki, Hiroaki
    Matsuyama, Toshiyuki
    Ezawa, Kazuma
    Koga, Yasuhiko
    Yatomi, Masakiyo
    Aoki-Saito, Haruka
    Chikamatsu, Kazuaki
    Hisada, Takeshi
    [J]. MEDICINA-LITHUANIA, 2019, 55 (07):
  • [24] Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience
    Emma, Rosalia
    Morjaria, Jaymin B.
    Fuochi, Virginia
    Polosa, Riccardo
    Caruso, Massimo
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2018, 12
  • [25] Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine
    Pavord, Ian D.
    Menzies-Gow, Andrew
    Buhl, Roland
    Chanez, Pascal
    Dransfield, Mark
    Lugogo, Njira
    Keene, Oliver N.
    Bradford, Eric S.
    Yancey, Steve W.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (03) : 1121 - +
  • [26] Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab
    Landi, Claudia
    Cameli, Paolo
    Vantaggiato, Lorenza
    Bergantini, Laura
    D'Alessandro, Miriana
    Perruzza, Marco
    Carleo, Alfonso
    Shaba, Enxhi
    Di Giuseppe, Fabrizio
    Angelucci, Stefania
    Bargagli, Elena
    Bini, Luca
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2021, 1869 (02):
  • [27] Severe Eosinophilic Asthma
    Bakakos, Agamemnon
    Loukides, Stelios
    Bakakos, Petros
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (09)
  • [28] Clusters of Severe Eosinophilic Asthma in a Korean Asthma Cohort
    Lee, Ji-Hyang
    An, Jin
    Won, Ha-Kyeong
    Seo, Bomi
    Kim, Jung-Hyun
    Park, So-Young
    Kim, Min-Hye
    Shin, Yoo Seob
    Jung, Jae-Woo
    Song, Woo-Jung
    Lee, Taehoon
    Kwon, Hyouk-Soo
    Lee, Jae Hyun
    Kim, Joo-Hee
    Kim, Sae-Hoon
    Chang, Yoon-Seok
    Cho, You Sook
    Nahm, Dong-Ho
    Jang, An-Soo
    Park, Jung-Won
    Yoon, Ho-Joo
    Cho, Sang-Heon
    Cho, Young-Joo
    Choi, Byoung Whui
    Moon, Hee-Bom
    Kim, Tae-Bum
    [J]. RESPIRATION, 2022, 101 (05) : 465 - 475
  • [29] Asthma treatments: new and emerging therapies
    Calhoun, Karen H.
    [J]. INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2015, 5 : S76 - S81
  • [30] Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population
    Kerkhof, Marjan
    Tran, Trung N.
    Soriano, Joan B.
    Golam, Sarowar
    Gibson, Danny
    Hillyer, Elizabeth V.
    Price, David B.
    [J]. THORAX, 2018, 73 (02) : 116 - 124
12345